While our current data show that IDO activity increases in stroke-diabetic mice and previous work has revealed enhanced levels of pro-inflammatory cytokines in stroke-diabetic mice [21], further details on innate and adaptive immune responses in the hippocampus in particular, are needed to completely characterize PSCI inflammation. Here, IDO1 is linked to stroke disorder.